Literature DB >> 19335127

Moyamoya disease: a summary.

Gordon M Burke1, Allan M Burke, Arun K Sherma, Michael C Hurley, H Hunt Batjer, Bernard R Bendok.   

Abstract

Moyamoya, meaning a "hazy puff of smoke" in Japanese, is a chronic, occlusive cerebrovascular disease involving bilateral stenosis or occlusion of the terminal portion of the internal carotid arteries (ICAs) and/or the proximal portions of the anterior cerebral arteries and middle cerebral arteries (MCAs). The Ministry of Health and Welfare of Japan has defined 4 types of moyamoya disease (MMD): ischemic, hemorrhagic, epileptic, and "other." The ischemic type has been shown to predominate in childhood, while the hemorrhagic type is more often observed in the adult population. The highest prevalence of MMD is found in Japan, with a higher female to male ratio. Studies have shown a possible genetic association of MMD linked to chromosome 17 in Japanese cases as well as in cases found in other demographics. During autopsy, intracerebral hematoma is found and most commonly serves as the major cause of death in patients with MMD. Moyamoya vessels at the base of the brain are composed of medium-sized or small muscular arteries emanating from the circle of Willis, mainly the intracranial portions of ICAs, anterior choroidal arteries, and posterior cerebral arteries, forming complex channels that connect with distal positions of the MCAs. Off of these channels are small tortuous and dilated vessels that penetrate into the base of the brain at the site of the thalamoperforate and lenticulostriate arteries. On angiography, there is the characteristic stenosis or occlusion bilaterally at the terminal portion of the ICAs as well as the moyamoya vessels at the base of the brain. Six angiographic stages have been described, from Stage 1, which reveals a narrowing of the carotid forks, to Stage 6, in which the moyamoya vessels disappear and collateral circulation is produced solely from the external carotid arteries. Cases with milder symptoms are usually treated conservatively; however, more severe symptomatic cases are treated using revascularization procedures. Surgical treatments are divided into 3 types: direct, indirect, and combined/other methods. Direct bypass includes superficial temporal artery-MCA bypass or use of other graft types. Indirect procedures bring in circulation to the intracranial regions by introducing newly developed vasculature from newly approximated tissues. These procedures may not be enough to prevent further ischemia; therefore, a combination of direct and indirect procedures is more suitable. This article will give a review of the epidemiology, natural history, pathology, pathophysiology, and diagnostic criteria, including imaging, and briefly describe the surgical treatment of MMD.

Entities:  

Mesh:

Year:  2009        PMID: 19335127     DOI: 10.3171/2009.1.FOCUS08310

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  45 in total

Review 1.  Twisted blood vessels: symptoms, etiology and biomechanical mechanisms.

Authors:  Hai-Chao Han
Journal:  J Vasc Res       Date:  2012-03-14       Impact factor: 1.934

2.  The maya behind moyamoya--the two extremes of the disease.

Authors:  Nandini Vijayakanthi; Thillothammal Natarajan
Journal:  Indian J Pediatr       Date:  2012-06-26       Impact factor: 1.967

3.  Clinical features and outcome in North American adults with idiopathic basal arterial occlusive disease without moyamoya collaterals.

Authors:  Manu S Goyal; Christopher L Hallemeier; Gregory J Zipfel; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Ralph G Dacey; Colin P Derdeyn
Journal:  Neurosurgery       Date:  2010-08       Impact factor: 4.654

4.  Elevated thyroid autoantibodies and intracranial stenosis in stroke at an early age.

Authors:  Zhenghao Shi; Xuting Zhang; Zhicai Chen; David S Liebeskind; Min Lou
Journal:  Int J Stroke       Date:  2013-09-12       Impact factor: 5.266

5.  Moyamoya disease, revascularisation surgery and anaesthetic considerations.

Authors:  Yashar Ilkhchoui; Pramod V Panikkath; Hugh Martin
Journal:  BMJ Case Rep       Date:  2014-01-08

6.  Champagne bottle neck sign in a patient with Moyamoya syndrome.

Authors:  Takafumi Shimogawa; Takato Morioka; Tetsuro Sayama; Takeshi Hamamura; Chiharu Yasuda; Shuji Arakawa
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

7.  Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.

Authors:  Ramin A Morshed; Adib A Abla; Daniel Murph; Jasmin M Dao; Ethan A Winkler; Jan-Karl Burkhardt; Kathleen Colao; Steven W Hetts; Heather J Fullerton; Michael T Lawton; Nalin Gupta; Christine K Fox
Journal:  J Clin Neurosci       Date:  2020-08-19       Impact factor: 1.961

8.  Diagnosis of moyamoya disease using 3-T MRI and MRA: value of cisternal moyamoya vessels.

Authors:  Takeshi Sawada; Akira Yamamoto; Yukio Miki; Ken-Ichiro Kikuta; Tomohisa Okada; Mitsunori Kanagaki; Seiko Kasahara; Susumu Miyamoto; Jun C Takahashi; Hidenao Fukuyama; Kaori Togashi
Journal:  Neuroradiology       Date:  2012-02-21       Impact factor: 2.804

9.  Mutation in pyrroline-5-carboxylate reductase 1 gene in families with cutis laxa type 2.

Authors:  Duane L Guernsey; Haiyan Jiang; Susan C Evans; Meghan Ferguson; Makoto Matsuoka; Mathew Nightingale; Andrea L Rideout; Sylvie Provost; Karen Bedard; Andrew Orr; Marie-Pierre Dubé; Mark Ludman; Mark E Samuels
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

Review 10.  Ischemic stroke and cerebral venous sinus thrombosis in pregnancy.

Authors:  Hannah J Roeder; Jean Rodriguez Lopez; Eliza C Miller
Journal:  Handb Clin Neurol       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.